Publication | Closed Access

Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation

NanoparticlesNanomedicineDextran-based NanoparticlesEngineeringChemotherapy SensitizationTherapeutic NanomaterialsMedicinePolymer-drug ConjugateNano-drug DeliveryMicroenvironment ModulationTumor TargetingPharmacologyRadiation OncologyTumor Microenvironment